Table 1.
Demographic and clinical information of the study cohorts.
train | test | p value | |
---|---|---|---|
N = 103 | N = 57 | ||
Age | 61.000 [51.000;69.000] | 60.000 [50.000;75.500] | 0.056 |
Sex | 0.052 | ||
female | 32 (31.068%) | 14 (24.561%) | |
male | 71 (68.932%) | 43 (75.439%) | |
Pathological-nuclear-grading | 0.001 | ||
low | 59 (57.282%) | 31 (54.386%) | |
high | 44 (42.718%) | 26 (45.614%) |